Table 3. Factors associated with ART initiation.
| †Variable | n | Unadjusted OR (95% CL) | ħAdjusted OR (95% CL) |
|---|---|---|---|
| Aged ≥50 vs. aged <50 years | 32965 | 1.12 (1.04, 1.20) | 1.13 (1.03, 1.25) |
| Male | 32965 | 0.76 (0.73, 0.80) | 0.66 (0.61, 0.70) |
| Urban clinic location | 32965 | 0.90 (0.86, 0.94) | 0.90 (0.88, 0.99) |
| Married | 32556 | 1.30 (1.24, 1.37)) | 1.54 (1.45, 1.65) |
| Using OI prophylaxis at baseline | 30824 | 1.25 (1.20, 1.32) | 1.30 (1.22, 1.38) |
| Advanced HIV status | 31634 | 1.86 (1.77, 1.96) | 2.53 (2.36, 2.70) |
| Hospitalized prior to ART start | 28320 | 0.75 (0.61, 0.92) | 0.66 (0.52, 0.83) |
| Disclosed HIV status at baseline | 32016 | 1.04 (0.99, 1.10) | 0.93 (0.87, 1.00) |
| Sample size | 25447 |
†Variables measured at enrollment.
Advance HIV status = CD4 < 200 cells / mm3 or WHO clinical stage 3 or 4.
ħWeighted for missing data on CD4 count, WHO clinical stage and BMI
OR–Odds Ratio, 95% CL: 95% Confidence Limits.